Noxopharm Ltd. (AU:NOX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Noxopharm Limited has announced the issuance of A$2.1 million in convertible notes to sophisticated investors, aimed at providing funding for the company to pursue potential opportunities without immediate financial pressure. The notes come with a 12% interest rate and options for investors, plus an additional potential A$500,000 investment from the company’s chairman pending shareholder approval. This move is part of Noxopharm’s strategy to progress in developing novel cancer and inflammation treatments, as well as enhancing mRNA vaccine technology.
For further insights into AU:NOX stock, check out TipRanks’ Stock Analysis page.